Krsnaa Diagnostics Reports Flat Financial Performance Amid Mixed Operational Metrics

Krsnaa Diagnostics, a small-cap player in the healthcare services sector, has recently undergone an evaluation adjustment that reflects changes in its financial metrics and market position. The company reported its financial performance for the quarter ending September 2025, which has been characterized as flat. Notably, Krsnaa Diagnostics achieved its highest operating cash flow at Rs 87.33 crore and net sales of Rs 205.99 crore during this period. Additionally, the company recorded a peak profit before depreciation, interest, and taxes (PBDIT) of Rs 59.16 crore, alongside a profit after tax (PAT) of Rs 23.95 crore.
However, certain metrics indicate areas of concern. The operating profit to interest ratio was at its lowest, recorded at 7.22 times, while the debt-equity ratio stood at 0.31 times, suggesting a cautious approach to leverage. The debtors turnover ratio also reached a low of 2.12 times, which may impact liquidity.

Despite these challenges, Krsnaa Diagnostics maintains a favorable valuation profile, with a price-to-earnings (PE) ratio of 31.30 and a return on capital employed (ROCE) of 11.01%. The company has seen an increase in institutional investor participation, which now accounts for 18.63% of its holdings.

For more insights on Krsnaa Diagnostics and its financial trend performance, you can Discover the Latest Mojo Score and Financial Trend Performance - SignUp in less than 2 Minutes and get FREE Premium Access.